prospects – Latest Health News

Alzheimer’s setback prompts rethink of Lilly, Biogen stock outlooks

Nov 23, 2016

—

by

By Lewis Krauskopf NEW YORK (Reuters) – Eli Lilly & Co’s massive setback for its experimental Alzheimer’s disease treatment on Wednesday sent investors scrambling to re-evaluate shares of the U.S. drugmaker and those of companies making competing therapies, including biotech stalwart Biogen Inc. Lilly shares tumbled 10.5 percent, and fell to their lowest point in…

Struggling Novartis heart drug boosted by new medical guidelines

May 21, 2016

—

by

creative

in Latest News

By Ben Hirschler LONDON (Reuters) – New global guidelines on the treatment of heart failure strongly endorse the use of Novartis’ Entresto, boosting the prospects for a drug that has struggled to gain traction since its launch last year. U.S. and European heart experts gave the highest “class 1” recommendation to Entresto for use in…

Struggling Novartis heart drug boosted by new medical guidelines

May 21, 2016

—

by

publisher

in Latest News

By Ben Hirschler LONDON (Reuters) – New global guidelines on the treatment of heart failure strongly endorse the use of Novartis’ Entresto, boosting the prospects for a drug that has struggled to gain traction since its launch last year. U.S. and European heart experts gave the highest “class 1” recommendation to Entresto for use in…

Tag: prospects

Alzheimer’s setback prompts rethink of Lilly, Biogen stock outlooks

Struggling Novartis heart drug boosted by new medical guidelines

Struggling Novartis heart drug boosted by new medical guidelines